Alverden Systems

Alverden is a biotechnology company pioneering a new class of therapeutics known as "Alverdens" to address unmet needs in animal health. These synthetic miniproteins are designed to offer the high potency and specificity of monoclonal antibodies while maintaining the stability and lower manufacturing costs associated with small molecules. The company's platform focuses on treating chronic conditions in companion animals, such as osteoarthritis, atopic dermatitis, and chronic kidney disease. By targeting validated biological pathways, Alverden aims to provide veterinarians with effective, long-acting treatments that are easier to administer than traditional biologics. Headquartered in New Haven, Connecticut, the company leverages advanced protein engineering to improve the quality of life for pets.